Bioscience Foundation · since 2005
Moving cancer prevention from early detection to interception.
A non-profit for research, education and advocacy. We help the public, former cancer patients and physicians understand the conditions that can drive cancer, and the science of reading them before a tumour forms.
What the Foundation does
Education programme
The public
Awareness campaigns, plain-language material, community workshops and digital content on risk factors, lifestyle and the conditions that can drive cancer.
- Campaigns
- Workshops
- Digital content
- Who it is for
- Everyone, from schools to community centres
- What it builds
- Knowledge that builds a prevention culture
Education programme
Former patients
Programmes on post-cancer care, regular follow-up and lifestyle, with support groups and resources written for people who have completed treatment.
- Follow-up
- Lifestyle
- Support groups
- Who it is for
- People who have completed cancer treatment
- What it builds
- Knowledge for the years after the disease
Education programme
Physicians
Evidence-based training modules, workshops and seminars with leading experts, from residents to senior practitioners.
- Training modules
- Seminars
- Case discussions
- Who it is for
- Physicians at every stage of their career
- What it builds
- Continuous education in cancer prevention
Research and collaboration
Research
Resources for research on understanding and intercepting the drivers of cancer, and partnerships with research institutes and the biotech sector.
- Research funding
- Partnerships
- Who it is for
- Researchers, institutes, medical societies
- What it builds
- Science that moves prevention earlier
Advocacy
Events
The Consensus Conference at the Italian Senate, national conferences with AIOM and in Milan, and the press coverage that followed.
- Italian Senate, 2023
- AIOM, Rome
- Milan, 2024
- Who it is for
- Institutions, press and the medical community
- What it builds
- Putting interception on the public agenda
Founded
a non-profit for research, education and advocacy in cancer prevention
Programmes
education programmes: the public, former cancer patients, physicians
Science library
open articles on the conditions that can drive cancer
Press
articles, agency reports and TV segments since 2023
Our mission
Early detection saves lives. Interception aims earlier still.
Early detection has played a monumental role in reducing cancer mortality. The Foundation works for the next step: understanding and reading the drivers of cancer, genomic instability, chronic inflammation, immune imbalance and gut dysbiosis, before they lead to disease.
Interception vs prevention01 · Scope
Research funding
Resources for research that focuses on understanding, identifying and targeting cancer drivers before they lead to disease.
Read more02 · Scope
Collaboration
Partnerships with research institutes, biotechnology firms and medical societies to study Cancer Driver Interception together.
Read more03 · Scope
Awareness and education
Campaigns and programmes that move the public conversation from finding cancer earlier to reading what drives it.
Read moreAdvocacy
A new approach to cancer prevention, presented at the Italian Senate.
On 11 October 2023, in the Sala Zuccari of the Senate in Rome, the Foundation convened the Consensus Conference on a new approach to cancer prevention in Italy, with oncologists, researchers and the President of AIOM.
Consensus Conference · Rome
“Nuovo approccio nella prevenzione dei tumori in Italia, primo modello al mondo”
Talks by Adriana Albini (IEO), Giuseppe Mucci, Rossana Berardi (Università Politecnica delle Marche) and Saverio Cinieri (AIOM), now on video.
Watch the video reviewPress coverage
agency reports, newspapers and TV segments, from ANSA and AGI to AIOM TV.
Board of directors
oncologists, researchers and leaders of Italian medical societies.
The people
A board drawn from oncology, research and the medical societies.
Chaired by Giuseppe Mucci, the board brings together names such as Adriana Albini, who chairs the Cancer Prevention Working Group of the American Association for Cancer Research, Saverio Cinieri, Francesco Cognetti, Rossana Berardi and Giuseppe Novelli.
Open science library
The conditions that can drive cancer, explained for everyone.
Genomic instability is the main driver: the build-up of acquired mutations when tumour suppressor genes stop repairing DNA. Around it sit chronic inflammation, the balance of the immune system and the gut microbiota.
Genomic instability
The progressive accumulation of acquired (somatic) mutations when tumour suppressor genes stop repairing DNA damage.
- Assessing genomic instability
- Analysing cfDNA
- Somatic mutation and the prodromal stage
- Molecular pathology in prevention
Inflammation
Chronic, low-grade inflammation as a condition that can drive tumour development.
Start readingGut microbiota
Dysbiosis of the intestinal flora and its links with inflammation, immunity, ageing and cancer.
- Dysbiosis
- How it is linked to cancer
- How to analyse gut microbiota
- Microbiota and Aging
- Microbiota and Cancer Development
Telomeres
The ends of chromosomes, their shortening with age and their role in genomic instability.
- Structure and functions
- Telomere shortening and cancer
- Telomere Shortening and Genomic Instability
- Telomeres in cancer
- Longer telomeres and cancer
For physicians
Continuous education, from residents to senior practitioners.
Evidence-based modules, workshops and case discussions with leading experts, so that physicians can bring the science of cancer drivers into everyday prevention.
Governance
Transparent by design.
How the Foundation is constituted, who leads it, and the rules it works by, all in one place.
Certificate of incorporationMission and vision
What the Foundation stands for and the paradigm it works to change.
Board of directors
Oncologists, researchers and leaders of Italian medical societies.
Internal policies
How the Foundation works, decides and handles data.
Sustainable development goals
How the work connects to the UN goals and the EU agenda.
The Foundation
Questions people ask
What we do, how we relate to the laboratory and to HELIXAFE, and how to work with us.
What is the Bioscience Foundation?
What is Cancer Driver Interception?
What does the Foundation do?
How is the Foundation related to Bioscience Institute and HELIXAFE?
Who sits on the board?
How can my organisation work with the Foundation?
Events and press
Conferences, national congresses and the press.
Press Release
La Prevenzione personalizzata dei tumori: “INTERCETTARE” i fattori di rischio
Video Review
20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente
Work with the Foundation
Bring the programmes to your school, association or medical society.
Education sessions, events, research collaborations: tell us what you have in mind and we will reply.